午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

TargetMol Chemicals Inc. 公司信息

公司名稱: TargetMol Chemicals Inc.
電話: -
電子郵件:marketing@targetmol.com
國籍:美國
網(wǎng)址: www.targetmol.com/
產(chǎn)品總數(shù):32367

公司提供產(chǎn)品列表

Clopidogrel 113665-84-2
AMG-7209;AM 7209;AM7209;AMG7209;AMG 7209;AM-7209 1623432-51-8
1,3-Benzenediacetonitrile 626-22-2
CLB-016;CLB 016;CLB016 1005636-29-2
Cysteic acid, L-;Cysteinic acid;NSC254030;L-Cysteic acid;NSC-254030;NSC 254030 498-40-8
Benzeneboronic acid, m-carboxy- 25487-66-5
Clemastine 15686-51-8
Benzene, 1,3-diphenoxy- 3379-38-2
Benserazide;Ro-44602;Serazide;Ro44602;Ro 44602 322-35-0
4-Ethoxycoumarin 35817-27-7
Pyrazophos;Curamil;HOE 02873 13457-18-6
Prodiamine;Barricade;Kusablock;Endurance;Blockade;Rydex 29091-21-2
A1899 498577-46-1
Ifenprodil 23210-56-2
G-Glu-Glu;H-gGlu-Glu-OH;gamma-Glutamyl-glutamic acid;G Glu Glu;GGluGlu 1116-22-9
PF-06465603;PF 06465603;PF06465603 1431626-44-6
AG1433;Tyrphostin AG-1433;Tyrphostin AG1433;Tyrphostin AG 1433;AG 1433;AG-1433 168836-03-1
Tonabersat;SB-220453 175013-84-0
AI 3-50089;AI3-50089;AI-3-50089 1237-75-8
Linamarin;Phaseolunatin 554-35-8
1588-A4 1698027-20-1
Apomorphine HCl hydrate;Apomorphine HCl;KW-6500;APL130277;APL-130277;Apomorphine Hydrochloride;APL 130277 41372-20-7
MS0019266;MS 0019266;MS-0019266 124285-22-9
m-PEG15-amine 80506-64-5
Isatin-O;Isatin-3-oxime 607-28-3
Methoxyamine HCl 593-56-6
DL-AP5 76326-31-3
ICI 162,846 84545-30-2
(R)-(-)-Ibuprofen 51146-57-7
C.I. Vat Yellow 2 129-09-9
Bryostatin 2 87745-28-6
8-Hydroxy-PIPAT oxalate 159651-91-9
1,2,3,4,5,6-Hexabromocyclohexane 1837-91-8
Pentabromophenol 608-71-9
Isoproterenol sulfate anhydrous;Aleudrin;Novodrin;Novodrine;dl-Isoproterenol sulfate;Norisodrine;Isoprenaline sulphate 299-95-6
Cimaterol 54239-37-1
INCB3619 791826-72-7
MRS1220 183721-15-5
RDEA-427;RDEA 427;RDEA427 914496-19-8
BRD2577;BRD 2577;BRD-2577 353781-42-7
2-Methyldecanenitrile;2-Cyanodecane 69300-15-8
Atomoxetine;HSDB 7352;HSDB-7352;HSDB7352 83015-26-3
CP55,667;CP 55667;CP-55667;CP-55,667 83002-04-4
Antalarmin hydrochloride 220953-69-5
Farnesylthiotriazole 156604-45-4
ML344;ML-344;ML 344 894856-92-9
Quinalizarin 81-61-8
LY5;LY-5;LY 5 1436382-03-4
Doxacurium Chloride;Nuromax;BWA938U;BW A 938U;BW-A-938U 106819-53-8
H-8 hydrochloride 113276-94-1
Pfn1-IN-C2;Pfn1 IN C2;Pfn1INC2;Pfn1 inhibitor C2 919010-22-3
4-Methylsalicylic acid 50-85-1
5-Bromo-5-nitro-1,3-dioxane 30007-47-7
1,4-Diaminobutane Dihydrochloride 333-93-7
Fluazuron;Acatak 86811-58-7
KDM5-C49;KDM5C49;KDM5 C49 1596348-16-1
Colcemid 477-30-5
PPAHV 175796-50-6
TH1834 dihydrochloride 2108830-09-5
SR31527;SR 31527;SR-31527 311814-78-5
Tri-o-cresyl phosphate;NSC 438;NSC-438;NSC438 78-30-8
Supinoxin 888478-45-3
CP-312 895470-67-4
Isoxepac 55453-87-7
SG-209 83440-03-3
Debio-0827;Debio0827;PL 37;PL-37;PL37;Debio 0827 935481-06-4
AICAR monophosphate 3031-94-5
DI-404;DI 404;DI404 2187412-79-7
DS-5272;DS 5272;DS5272 1235575-97-9
iNUB 352336-00-6
KRM-II-81;KRM-II 81;KRM-II81 2014348-91-3
MS012;MS-012;MS 012 2089617-83-2
Methyl p-coumarate 3943-97-3
IP7e 500164-74-9
PF-06737007 1863905-38-7
PF-04859989;PF04859989;PF 04859989 34783-48-7
Desacetylcephalothin sodium;Dacet;Deacetylcephalothin sodium salt 5547-29-5
Phensuximide;AI320372;AI3 20372;AI3-20372 86-34-0
resorufin galactopyranoside 95079-19-9
Synthalin sulfate 182285-12-7
SR 2640 hydrochloride 146662-42-2
Desmeninol 583-91-5
Octadecanonitrile;NSC 5541;NSC5541;NSC-5541 638-65-3
Cefalonium Dihydrate(5575-21-3 free base) 1385046-35-4
PF-46396;PF 46396;PF46396 1207481-21-7
DDD85646 1215010-55-1
Tildacerfont 1014983-00-6
VER-00158411 1174664-88-0
AT-IAP;AT IAP;ATIAP 1403898-55-4
Gallopamil, (-)-;(-)-Methoxyverapamil;(S)-Gallopamil;(-)-Gallopamil;(-)-D 600 36622-40-9
Cyslabdan 956507-17-8
TachypleginA-2;TachypleginA2;tA-2;tA2;TachypleginA 2;tA 2 296798-88-4
GBR 13069 dihydrochloride 67469-45-8
Memoquin 616885-87-1
Xylopropamine Hydrobromide 861007-60-5
Photoregulin1 1003736-23-9
BPKDi 1201673-28-0
ARC 239 dihydrochloride 55974-42-0
RU 28318, potassium salt 76676-34-1
NPD926;NPD-926;NPD 926 384361-79-9
Copyright 2007? ChemicalBook. All rights reserved.